NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY, OR CONSTITUTE A VIOLATION OF, THE RELEVANT LAWS OF THAT JURISDICTION OR REQUIRE EURONEXT AND/OR ATHEX TO TAKE ANY FURTHER ACTION.
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report second quarter financial results, before the US markets open on Thursday, August 7, 2025.
The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Free Cash Flow, Net cash / debt and Operating working capital days. See exhibit I for more details on these alternative performance measures.
Local 120 Members Demand Fair Contract, Prepare to Strike
MINNEAPOLIS, July 30, 2025 /PRNewswire/ -- Teamsters at Sysco Minnesota have voted unanimously to authorize a...
Kansas City Drivers Choose Representation with Local 41, Set to Become Part of National Master Agreement
KANSAS CITY, Mo., July 30, 2025 /PRNewswire/ -- Carhaul...
PENNVEST program assists Pennsylvania homeowners with sewer and septic system costs
HARRISBURG, Pa., July 30, 2025 /PRNewswire/ -- The latest episode of PHFA's "Close To Home"...
– Nuvisertib (TP-3654), an oral investigational highly selective PIM-1 kinase inhibitor, is being evaluated in patients with relapsed or refractory myelofibrosis (MF) –
MARLBOROUGH, Mass.,...
Ohio's Perry's Victory Memorial Hosts Declaration 250 Event
PUT-IN-BAY, Ohio, July 30, 2025 /PRNewswire/ -- As the United States prepares to celebrate the 250th anniversary...